Compile Data Set for Download or QSAR
Report error Found 63 Enz. Inhib. hit(s) with all data for entry = 10691
TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM559897(US11377423, Cmpd 3A)
Affinity DataIC50: 4nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM24624(MGCD-0103 | N-(2-aminophenyl)-4-({[4-(pyridin-3-yl...)
Affinity DataIC50: 6nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM50457079(CS-055 | CS055 | Chidamide | Epidaza in China | HB...)
Affinity DataIC50: 9nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM559896(US11377423, Cmpd 2A)
Affinity DataIC50: 12nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM19410(benzamide-type inhibitor, 3 | CHEMBL27759 | pyridi...)
Affinity DataIC50: 14nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559896(US11377423, Cmpd 2A)
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM559896(US11377423, Cmpd 2A)
Affinity DataIC50: 18nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM50457079(CS-055 | CS055 | Chidamide | Epidaza in China | HB...)
Affinity DataIC50: 22nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559897(US11377423, Cmpd 3A)
Affinity DataIC50: 22nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM559897(US11377423, Cmpd 3A)
Affinity DataIC50: 23nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM24624(MGCD-0103 | N-(2-aminophenyl)-4-({[4-(pyridin-3-yl...)
Affinity DataIC50: 23nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM24624(MGCD-0103 | N-(2-aminophenyl)-4-({[4-(pyridin-3-yl...)
Affinity DataIC50: 26nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM19410(benzamide-type inhibitor, 3 | CHEMBL27759 | pyridi...)
Affinity DataIC50: 34nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559894(US11377423, Cmpd 1A)
Affinity DataIC50: 36nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM19422(N-acetyldinaline | N-(2-aminophenyl)-4-acetamidobe...)
Affinity DataIC50: 38nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM19422(N-acetyldinaline | N-(2-aminophenyl)-4-acetamidobe...)
Affinity DataIC50: 38nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM19422(N-acetyldinaline | N-(2-aminophenyl)-4-acetamidobe...)
Affinity DataIC50: 39nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM19422(N-acetyldinaline | N-(2-aminophenyl)-4-acetamidobe...)
Affinity DataIC50: 39nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM19410(benzamide-type inhibitor, 3 | CHEMBL27759 | pyridi...)
Affinity DataIC50: 41nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM50457079(CS-055 | CS055 | Chidamide | Epidaza in China | HB...)
Affinity DataIC50: 49nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM178100(BRD3308 | US11377423, Cmpd 1)
Affinity DataIC50: 68nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM178100(BRD3308 | US11377423, Cmpd 1)
Affinity DataIC50: 68nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559883(US11377423, Compound 6)
Affinity DataIC50: 80nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559887(US11377423, Compound 12)
Affinity DataIC50: 84nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM559887(US11377423, Compound 12)
Affinity DataIC50: 90nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM178097(4-Acetamido-N-(2-amino-5-fluorophenyl)benzamide (7...)
Affinity DataIC50: 106nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM19422(N-acetyldinaline | N-(2-aminophenyl)-4-acetamidobe...)
Affinity DataIC50: 110nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM19422(N-acetyldinaline | N-(2-aminophenyl)-4-acetamidobe...)
Affinity DataIC50: 110nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM559894(US11377423, Cmpd 1A)
Affinity DataIC50: 120nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM178097(4-Acetamido-N-(2-amino-5-fluorophenyl)benzamide (7...)
Affinity DataIC50: 153nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM559894(US11377423, Cmpd 1A)
Affinity DataIC50: 157nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559888(US11377423, Compound 5)
Affinity DataIC50: 299nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM559887(US11377423, Compound 12)
Affinity DataIC50: 304nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559881(US11377423, Compound 4)
Affinity DataIC50: 376nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559884(US11377423, Compound 7)
Affinity DataIC50: 418nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559885(US11377423, Compound 8)
Affinity DataIC50: 436nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM178097(4-Acetamido-N-(2-amino-5-fluorophenyl)benzamide (7...)
Affinity DataIC50: 479nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM559880(US11377423, Compound 3)
Affinity DataIC50: 551nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM178100(BRD3308 | US11377423, Cmpd 1)
Affinity DataIC50: 1.25E+3nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM178100(BRD3308 | US11377423, Cmpd 1)
Affinity DataIC50: 1.25E+3nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM559883(US11377423, Compound 6)
Affinity DataIC50: 1.38E+3nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM178100(BRD3308 | US11377423, Cmpd 1)
Affinity DataIC50: 1.42E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM178100(BRD3308 | US11377423, Cmpd 1)
Affinity DataIC50: 1.42E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM559888(US11377423, Compound 5)
Affinity DataIC50: 1.73E+3nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 3(Human)
The Broad Institute

US Patent
LigandPNGBDBM178099(4-Acetamido-N-(2-amino-4-chlorophenyl)benzamide (9...)
Affinity DataIC50: 2.05E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM559881(US11377423, Compound 4)
Affinity DataIC50: 2.12E+3nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
The Broad Institute

US Patent
LigandPNGBDBM559880(US11377423, Compound 3)
Affinity DataIC50: 2.18E+3nMAssay Description:The following non-trypsin coupled in-vitro HDAC enzymatic endpoint assay was used to assay the compounds of the invention. Below is a standardized pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM559883(US11377423, Compound 6)
Affinity DataIC50: 3.12E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM559888(US11377423, Compound 5)
Affinity DataIC50: 3.54E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

TargetHistone deacetylase 2(Human)
The Broad Institute

US Patent
LigandPNGBDBM559881(US11377423, Compound 4)
Affinity DataIC50: 4.44E+3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/5/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: